Save Sight Institute Archives - Insight

Aussie study offers new MIGS head-to-head comparison

Myles Hume — Tue, 15 Mar 2022 02:47:19 +0000

The Glaukos iStent is one of few MIGS procedures reimbursed as a standalone procedure.

Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no significant difference in intraocular
Read More

The post Aussie study offers new MIGS head-to-head comparison appeared first on Insight.

Inherited retinal diseases – the patient journey

Staff Writer — Mon, 31 Jan 2022 21:43:43 +0000

Figure 3: A retinal organoid used for functional genomic investigations for variant classification. Image: Prof Robyn Jamieson.

At the completion of this CPD activity, optometrists will have developed their knowledge of the patient journey following referral for inherited retinal diseases (IRDs). Including: The
Read More

The post Inherited retinal diseases – the patient journey appeared first on Insight.

Aussie-led dry eye registry paints fuller picture of disease landscape

Staff Writer — Tue, 18 Jan 2022 00:00:24 +0000

Dry eye disease prevalence ranges from 5% to 50% globally.

Eyecare professionals are being reminded to participate in a new dry eye registry, led by Sydney’s Save Sight Institute (SSI), that will help the industry better determine the long-term effectiveness
Read More

The post Aussie-led dry eye registry paints fuller picture of disease landscape appeared first on Insight.

Siblings treated with Luxturna gene therapy in Australian first (video included)

Myles Hume — Sun, 10 Oct 2021 22:46:31 +0000

Luxturna being delivered to one of the recipients via a subretinal injection. Image: A/Prof Matthew Simunovic

Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular gene therapy. Those involved with delivering the novel treatment say it
Read More

The post Siblings treated with Luxturna gene therapy in Australian first (video included) appeared first on Insight.

KeraClub 2021 to have COVID focus, details announced

Myles Hume — Tue, 05 Oct 2021 20:14:36 +0000

Prof Stephanie Watson (from left), A/Prof Mark Roth, Chloe Davies, Larry Kornhauser, Michelle Pritchard and Dr Himal Kandel.

Organisers of KeraClub 2021 have unveiled the speaker line up for this month’s event, which will have a particular focus on managing keratoconus in the COVID-19 era and beyond. The annual meeting for
Read More

The post KeraClub 2021 to have COVID focus, details announced appeared first on Insight.

Infrared light could replace injections for macular oedema

Staff Writer — Tue, 27 Jul 2021 22:50:33 +0000

The study is being led by the Save Sight Institute's Macular Research Group, within the University of Sydney.

A clinical trial at Sydney Eye Hospital is evaluating the safety and efficacy of using infrared light to treat macular oedema from retinal vein occlusions, instead of the current standard treatment of
Read More

The post Infrared light could replace injections for macular oedema appeared first on Insight.

Sole Australian among world’s top 100 female ophthalmologists

rhiannon bowman — Tue, 06 Apr 2021 21:21:34 +0000

As an academic eye surgeon, Prof Stephanie Watson is one of only three female professors out of 34 in Australia.

The Save Sight Institute’s Professor Stephanie Watson has been recognised as one of the world’s top 100 female ophthalmologists. She is the only Australian to make the 2021
Read More

The post Sole Australian among world’s top 100 female ophthalmologists appeared first on Insight.

’90 seconds without blinking’ – Sydney ophthalmologists repurpose cholesterol drug into dry eye therapy

Myles Hume — Tue, 16 Mar 2021 22:01:08 +0000

Dr Kenneth Ooi and Prof Stephanie Watson say the research needs to overcome funding hurdles to advance further.

Two Australian ophthalmologists are repurposing a common cholesterol-lowering drug into a topical ocular therapy for dry eye and blepharitis, which was given to a patient as part of an initial trial
Read More

The post ’90 seconds without blinking’ – Sydney ophthalmologists repurpose cholesterol drug into dry eye therapy appeared first on Insight.

Optometry webinar to shed light on keratoconus and dry eye registries

rhiannon bowman — Mon, 22 Feb 2021 01:54:30 +0000

Keratoconus is a progressive disease and can advance quickly in adolescents and young adults.

A free webinar for optometrists managing keratoconus and dry eye patients will explain how they can access one of the few clinical registries worldwide that engages optometrists. The Save Sight Institute
Read More

The post Optometry webinar to shed light on keratoconus and dry eye registries appeared first on Insight.

Sydney researchers identify improved topical therapy for microbial keratitis

rhiannon bowman — Tue, 16 Feb 2021 20:17:06 +0000

Resistant organisms can lead to ocular infection that can irreversibly damage eye structures.

An ongoing clinical study in Sydney has uncovered an alternative topical therapy to treat microbial keratitis in lieu of the antibiotics recommended by Therapeutic Guidelines Australia. The Bacterial Ocular
Read More

The post Sydney researchers identify improved topical therapy for microbial keratitis appeared first on Insight.